| |
Centre for Policy on Ageing | |
 | |
|
| Effect of Tamoxifen on bone fractures in older nursing home residents | | Author(s) | Brenda Breuer, Sylvan Wallenstein, Richard Anderson |
| Journal title | Journal of the American Geriatrics Society, vol 46, no 8, August 1998 |
| Pages | pp 968-972 |
| Keywords | Older women ; Cancer ; Drugs ; Fractures ; Patients [nursing homes] ; United States of America. |
| Annotation | Tamoxifen is a drug used in the treatment of breast cancer. This US study evaluated the association between Tamoxifen treatment and rate of bone fractures in 93,031 female nursing home residents, aged 65 years and over, comparing women who were receiving the drug with those who were not, over a one and a half-year period. Results showed that during that period, the fracture rates were 7.62% in women not treated with Tamoxifen, 3.20% in women receiving 10 mg daily, and 6.73% in women receiving 20 mg daily. The study concluded that standard treatment of 20 mg Tamoxifen daily offered no apparent protection against bone fractures in older nursing home residents, however, a daily 10 mg dose appeared to be effective. (AKM). |
| Accession Number | CPA-981002403 A |
| Classmark | BD: CK: LLD: CUF: LHB:LF: 7T |
Data © Centre for Policy on Ageing |
|
| ...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|